Reduction of intrathecal immunoglobulin levels with ocrelizumab treatment in relapsing and primary progressive multiple sclerosis

被引：0
|
作者：
Weber, Martin [1 ]
Gelfand, Jeffrey [2 ]
Bar-Or, Amit [3 ]
Cameron, Briana [4 ]
Ramesh, Akshaya [4 ]
Anania, Veronica [4 ]
von Budingen, H. -Christian [5 ]
Herman, Ann [4 ]
Spiciarich, David [4 ]
Grondey, Katja [1 ]
Schuetz, Konstantin [1 ]
Winger, Ryan [4 ]
Jia, Xiaoming [4 ]
Harp, Christopher [4 ]
Cross, Anne [6 ]
机构：
[1] Univ Hosp Gottingen, Gottingen, Germany
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[4] Genentech Inc, South San Francisco, CA USA
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Washington Univ Sch Med, St Louis, MO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P653/1074
引用
收藏
页码：570 / 571
页数：2
相关论文
共 50 条
  • [1] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis
    Mildiner, Sorcha
    Malnick, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1692 - 1693
  • [2] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY
    Hauser, Stephen L.
    Belachew, Shibeshih
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1694 - 1694
  • [3] Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Chognot, Cathy
    Hughes, Richard
    Koendgen, Harold
    Pasquarelli, Noemi
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 97 (16) : E1546 - E1559
  • [4] Blood neurofilament light levels are reduced following ocrelizumab treatment in patients with relapsing and primary progressive multiple sclerosis
    Bar-or, A.
    Thanei, G. -A.
    Harp, C.
    Cross, A.
    Hauser, S.
    Jia, X.
    Kuhle, J.
    Leppert, D.
    Model, F.
    Fiore, D.
    Koendgen, H.
    Hendricks, R.
    Fischer, S.
    Manfrini, M.
    Herman, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 197 - 197
  • [5] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Hartung, H. -P.
    Arnold, D. L.
    Bar-Or, A.
    Comi, G.
    de Seze, J.
    Giovannoni, G.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 658 - 659
  • [6] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Rammohan, Kottil W.
    Hartung, Hans-Peter
    Arnold, Douglas L.
    Bar-Or, Amit
    Comi, Giancarlo
    de Seze, Jerome
    Giovannoni, Gavin
    Hauser, Stephen L.
    Hemmer, Bernhard
    Kappos, Ludwig
    Lublin, Fred
    Montalban, Xavier
    Selmaj, Krzysztof
    Traboulsee, Anthony
    Chin, Peter
    Li, Carrie
    Mairon, Nicole
    Napieralski, Julie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 31 - 32
  • [7] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
  • [8] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Hughes, Richard
    Prajapati, Kalpesh
    Koendgen, Harold
    Pradhan, Ashish
    Wolinsky, Jerry S.
    NEUROLOGY, 2020, 94 (15)
  • [9] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [10] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
12345